Inactive Instrument

Concordia International Corp Share Price Toronto S.E.

Equities

Duration

Period

Style

Aberdeen Asset Management : Equity, Macro hedge funds look to bounce back from a tough year	23/16/23	RE
Exclusive: Endo considers sale of Paladin Labs to Knight Therapeutics - sources	04/16/04	RE
Exclusive: Canada drugmaker Cipher mulls sale - sources	01/16/01	RE
Exclusive: Canada drugmaker Cipher mulls sale - sources	01/16/01	RE
Concordia International : Canadian drugmaker Concordia says CEO to step down	22/16/22	RE
Drug maker Concordia in talks to sell equity stake: sources	03/16/03	RE
Concordia Healthcare : TRLPC: Valeant’s falling secondary loan price pulls pharma companies down	23/15/23	RE
Canadian Natural Resources : Slumping oil, China worries hit TSX's resource stocks	20/15/20	RE
Concordia Healthcare : boosts drug portfolio with $1.9 billion deal	08/15/08	RE

Concordia International Corp. : Adds European Pharmaceutical Industry Expert to its Board of Directors	29/18/29	PR
Concordia International Corp. : Announces Addition of Pharmaceutical Industry Expert to its Board of Directors	16/18/16	PR
Concordia International Corp. : Announces Intention To Rebrand As ADVANZ PHARMA Following Its Successful Recapitalization	09/18/09	PR
Concordia International Corp. : Announces Special Meeting of Shareholders To Approve Name Change	06/18/06	PR
Concordia International Corp. : Provides Further Update On Its Recently Completed Recapitalization Transaction and the Issue Price of its Private Placement	12/18/12	PR

Concordia International : discute de la vente d'une participation minoritaire-sces	03/16/03
Concordia Healthcare : rachète Amdipharm pour $1,9 md	08/15/08
Les valeurs à suivre mardi 8 septembre 2015 à Wall Street -	08/15/08
CONCORDIA HEALTHCARE : s'offre Amdipharm Mercury	08/15/08

Sector